Quit, or patch up!

A Padma Shri and former Indian Medical Association president argues for e-cigarettes and nicotine patches as a harm-reduction strategy. Time for a smoking debate

easwaran

SB Easwaran | December 31, 2018 | Delhi


#smoking   #KK Aggarwal   #cancer   #tobacco   #Indian Medical Association   #nicotine patch   #e-cigarettes  
Dr KK Aggarwal, all for safer alternatives
Dr KK Aggarwal, all for safer alternatives

Should  e-cigarettes, nicotine patches, other nicotine-replacement therapies, and heat-not-burn (HNB) tobacco products be encouraged? Are they less harmful than smoking and traditional ways of taking tobacco? The current tobacco debate, as always, is between the hard line and pragmatism. Both sides have cogent arguments in this suspicion-ridden contest, clouded by the shadow wars staged by big tobacco and pharma lobbies.
 
Among those in India who argue for a pragmatic approach is leading cardiologist Dr KK Aggarwal, a Padma Shri and former president of the Indian Medical Association (IMA). “If a patient tells me he smokes, I tell him he must quit. As a doctor, my ethics dictate that I do that – and I always advise young people to never consume tobacco in any form. Or get into other drug dependencies, for that matter. I also took part in the campaign for bigger pictorial warnings on cigarette packets,” he says. “But when a patient with a long history of tobacco use is unable to stop, or does not want to, what can a doctor do? A pragmatic solution is to suggest that the patient switch to less harmful ways of getting his nicotine high. Also, these aids may help him quit ultimately.”
 
Nicotine patches or e-cigarettes may help smokers or tobacco chewers assuage the craving. Since there’s no smoke or tar, nor any chewing, the risk of lung and oral cancer is lower. Though nicotine is highly addictive, causes hypertension, constricts and hardens arteries, and increases the heart rate and the risk of blood clotting, it’s not per se known to cause cancer.
 
Aware that controversy hovers over the topic, Dr Aggarwal sets down strong caveats: sale should be restricted to those above 21; some items must be available only on prescription; efforts should be redoubled to discourage tobacco use in young people; and students should be cautioned on the health risks of tobacco use and other dependencies, right at school level. Since a ban on tobacco can neither be effected nor prove effective, he says there should be enough leeway for “harm reduction”. He cites reports from Public Health England; the US National Academy of Sciences, Engineering and Medicine; the American Cancer Society; Cancer Research UK; and the Royal College of Physicians.
 
“Harm reduction” is a new buzzword, but those on the other side call it a euphemism coined to ease in new fashions that benefit tobacco giants. They suspect a nascent tobacco-pharma lobby is at work: after all, the nicotine in the patches and vaping fluids comes from tobacco. Researchers at the University of California, San Francisco, say “the pharmaceuticalisation of the tobacco industry” has begun.
 
In the US, as across the world, the debate is polarised. On December 18, surgeon-general Jerome Adams issued a rare public health advisory calling for immediately addressing the vaping epidemic among teenagers. He warned that nicotine exposure in adolescence can harm the developing brain. Vaping fluids in kid-friendly flavours and e-cigarettes with sleek gadget appeal would hook teens and make them adult smokers. Or marijuana users, since teens start using the devices for vaping marijuana too. On the other hand, in a November 15 article in the Washington Post, Tom Miller, a former attorney-general, wrote that if smokers are denied safer alternatives because of the overreaction against e-cigarettes, the country risked losing the huge fall in smoking rates (from 24 percent to 14 percent) achieved over 20 years.
 
There is also the controversial case of Derek Yach, a former World Health Organisation (WHO) hand who took part in the scripting of the Framework Convention on Tobacco Control. He now heads the Foundation for a Smoke-Free World, which advocates the use of e-cigarettes, patches, etc. The foundation is promoted by Philip Morris International, a tobacco giant.
 
Dr Aggarwal, like Yach, is all for switch-and-quit. Even if quitting does not happen, the harm at least is reduced, he reasons. As for behavioural therapies for quitting tobacco, he says they are not practicable on a large scale in India: counselling takes months and there aren't enough counsellors. 

The debate smokes. Or perhaps does the dragon, a vaping trick of exhaling fumes through the nostrils and the corners of the mouth at the same time. It's a favourite with teenagers.
 
sbeaswaran@governancenow.com

(The article appears in January 15, 2019 edition. The last paragraph was modified for clarity after publication in print.)

Comments

 

Other News

3 out of 4 Covid-19 patients in 21-60 yrs age group

Contrary to the perception that the elderly are more at risk from Covid-19, in India as many as 41.88% of corona positive cases are between 21 to 40 years of age. Also, 32.82% positive cases are between 41 to 60 years, followed by 16.69% cases above the age of 60 years and 8.61% coronavirus positive cases

Why everyone should wear mask

In view of the increasing number of COVID -19 cases in the country, the ministry of health and family welfare (MoHFW) has now advised that everyone must voluntarily wear a mask and especially those living in densely populated areas.   Not just as a matter of maintaining personal hygiene

Fighting Covid-19, India has realized its collective strength: PM

In the face of the Covid-19 pandemic, people of India have realized their collective strength, prime minister Narendra Modi said in a short video message Friday morning. He also urged people to light lamps Sunday night as a gesture of this collectivity. “Today marks nine days of the na

COVID-19 demobilisation: Lessons for public governance

Demobilization, like its predecessor – demonetization, is another decision gone bad in implementation.  In both instances a careful public administrative action through its governance systems could have saved the magnitude of impact particularly on the most vulnerable sections of the society. Th

Don’t fear Corona, fight it

In a bid to break the “chain of transmission” of the deadly Covid-19, India, a country with more than 1.3 billion population, observed a voluntary ‘Janata Curfew’ on March 22. This has been followed by a 21-day, nationwide lockdown from March 24. Prime minister Narendra Modi also re

Sci-Tech Empowered Committee set up for COVID-19

To take speedy decisions on research and development for Sars-Cov-2 virus and COVID-19, the government has constituted a Science and Technology Empowered Committee. The committee, set up on March 29 and chaired by Niti Aayog member, professor Vinod Paul and professor K Vijay Raghavan, princi



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter